Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochlorperazine plus standard antiemetics for prevention of delayed nausea and vomiting with oxaliplatin chemotherapy
TCTR20210526005Phase 3Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prochlorperazine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Chulalongkorn University. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
prochlorperazine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on TCTR20210526005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210526005.